6PP-71351-83637 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-18
Dose 1 — Pfizer-BioNTech
2021-03-27
Registered in v-safe
2021-03-27
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-04-01
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-08
Dose 2 — Pfizer-BioNTech
2021-04-08
Health check-in — day 0, dose 2
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-04-09
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain

Adult check-in
2021-04-12
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-14
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-17
Health check-in — day 7, dose 2
Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-24
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-04-30
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2021-05-08
Health check-in — day 28, dose 2
Feeling: Fair

Adult check-in
2021-05-13
Survey response — day 35, dose 2
MedDRA: Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: I am experiencing a suspected demyelinating relapse

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-13
Report sent to call center — day 35, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-20
Survey response — day 42, dose 2
MedDRA: Neuromyelitis optica spectrum disorder, Pre-existing disease, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Having a NMO relapse · Healthcare visit (other): MRI, steroids

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-20
Report sent to call center — day 42, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-10
Health check-in — 3 months, dose 2
Feeling: Fair

Adult check-in
2021-08-26
Dose 3 — Pfizer-BioNTech
2021-10-07
Survey response — 6 months, dose 2
MedDRA: Blindness, Condition aggravated, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: I received a 3rd dose of Pfizer which caused my neurological disease to relapse, lost my vision and had to have 5 days of IV solumedrol and 2 days of IVIG

MedDRA releases: 2024-11 · check-in free text available
2021-10-07
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-10-08
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2021-10-13
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-18	Pfizer-BioNTech
2	2021-04-08	Pfizer-BioNTech
3	2021-08-26	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-05-13	Unsuccessful
2021-05-20	Unsuccessful
2021-10-07	Unsuccessful

Free text

Release 8 — day 35, dose 2

2021-05-13

Symptoms: I am experiencing a suspected demyelinating relapse

Release 8 — day 42, dose 2

2021-05-20

Symptoms: Having a NMO relapse

Healthcare visit (other): MRI, steroids

Release 10 — 6 months, dose 2

2021-10-07

Symptoms: I received a 3rd dose of Pfizer which caused my neurological disease to relapse, lost my vision and had to have 5 days of IV solumedrol and 2 days of IVIG

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	✓	✓	✓
SD	Blindness	·	·	✓
SD	Condition aggravated	·	·	✓
SD	Neuromyelitis optica spectrum disorder	✓	✓	✓
SD	Pre-existing disease	✓	✓	✓
SD	Unevaluable event	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release